Literature DB >> 93985

Bleomycin pharmacokinetics in man. II. Intracavitary administration.

D S Alberts, H S Chen, M Mayersohn, D Perrier, T E Moon, J F Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 93985     DOI： 10.1007/bf00254085

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  7 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

4.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency.

Authors:  G E Mawer; S B Lucas; B R Knowles; R M Stirland
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

5.  Bleomycin pharmacokinetics in man. I. Intravenous administration.

Authors:  D S Alberts; H S Chen; R Liu; K J Himmelstein; M Mayersohn; D Perrier; J Gross; T Moon; A Broughton; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

6.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

7.  Intracavitary bleomycin in the management of malignant effusions.

Authors:  W Paladine; T J Cunningham; R Sponzo; M Donavan; K Olson; J Horton
Journal:  Cancer       Date:  1976-11       Impact factor: 6.860
  7 in total
  8 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

3.  High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.

Authors:  R Mahdadi; A Kenani; N Pommery; J Pommery; J P Hénichart; M Lhermitte
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Intrapleural etoposide for malignant effusion.

Authors:  P Y Holoye; D G Jeffries; H M Dhingra; F A Holmes; M Raber; M S Engineer; R A Newman
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.

Authors:  S Koldsland; J L Svennevig; G Lehne; E Johnson
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

6.  British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

7.  Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.

Authors:  Y M Peng; D S Alberts; H S Chen; N Mason; T E Moon
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

8.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.